Join
Live feed
·
INSIDERFilingvia Quantisnow
Puma Biotechnology Inc logo

Director Cesano Alessandra exercised 50,000 shares at a strike of $2.93 and sold $566,994 worth of shares (62,150 units at $9.12) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 56,700 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBYI (Puma Biotechnology Inc) and more on Quantisnow.